KLF17 inhibits cancer cell invasion in lung adenocarcinoma by suppressing the phosphorylation of p38 MAPK and inhibiting the urokinase fibrinogen activator induced by p38 MAPK/SRC signaling pathway (114). Here, KLF17 is linked to cancer.